GLP1R and kidney disorder: TS=("GLP-1 receptor agonist" OR "glucagon-like peptide-1 receptor agonist" OR "GLP-1RA" OR "liraglutide" OR "semaglutide" OR "dulaglutide" OR "exenatide" OR "albiglutide" OR "lixisenatide" OR "efpeglenatide") AND TS=("type 2 diabetes" OR "T2DM") AND TS=("major adverse cardiovascular events" OR "MACE" OR "cardiovascular outcomes" OR "myocardial infarction" OR "stroke" OR "cardiovascular death") AND TS=("renal outcomes" OR "kidney disease" OR "nephropathy" OR "renal adverse events")